Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) –Market Forecast till 2032
Overview of the Market
In 2022, the blood glucose monitoring market in Asia Pacific was estimated to be worth USD 1.1 billion. The blood glucose monitoring market in Asia Pacific is expected to expand at a compound annual growth rate (CAGR) of 13.60% from 2023 to 2032, from USD 1.25 billion in 2023 to USD 3.46 billion. The primary factors propelling the market's growth are the increasing prevalence of diabetes and the growing need for reliable glucose monitoring devices.
The Asia Pacific Blood Glucose Monitoring Market CAGR is being driven by the increasing prevalence of diabetes in the region. Most people with diabetes reside in Asia-Pacific countries, such as China and India, where the prevalence rate is typically about 8.5%. Diabetes is effectively diagnosed and treated with blood glucose-measuring devices. The growing number of diabetics utilizing blood glucose monitoring devices is driving the market. One of the main causes of the disease condition, especially type 2 diabetes, is thought to be obesity. Furthermore, other factors, such as innovations and technological developments, facilitate the measurement of blood glucose levels. The early identification of hypoglycemic and hyperglycemic conditions, which these devices aid with, usually propels the market for glucose monitoring.
Perspectives on Market Segments
Based on product type, the Asia Pacific blood glucose monitoring market is segmented into three categories: CGM, flash glucose monitoring, and invasive glucose monitoring.
Both Type 1 and Type 2 diabetes are included in the Asia Pacific Blood Glucose Monitoring market segmentation, which is based on its application.
Diagnostic centers, hospitals, and clinics are included in the end-user-based market segmentation for blood glucose monitoring in Asia Pacific.
Local Perspectives
The report offers market insights for Asia-Pacific by region. Over the anticipated period, the China Blood Glucose Monitoring market is anticipated to hold a dominant position. Demand in the industry has been driven by a significant portion of the country's patient population. The rise of the sector has been spurred by the opportunity to spend more money on disease control and treatment. Increased consumer awareness, easier access to products, and company growth by industry players nationwide will all contribute to the market's growth. Additionally, the nation's aging population is expected to increase industry demand because older adults are more likely to develop type 2 diabetes. Government initiatives and campaigns to promote diabetes care will also encourage company expansion.
Key Players
Abbott Laboratories, Arkay Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd., Sphere Medical, Dexcom, LifeScan, and other prominent companies are part of the Asia Pacific blood glucose monitoring market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 30
TABLE 2 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 44
TABLE 3 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY COUNTRY, 2019–2032 (USD MILLION) 45
TABLE 4 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 45
TABLE 5 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR BLOOD GLUCOSE METER, BY COUNTRY, 2019–2032 (USD MILLION) 46
TABLE 6 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TESTING STRIPS, BY COUNTRY, 2019–2032 (USD MILLION) 46
TABLE 7 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR LANCETS, BY COUNTRY, 2019–2032 (USD MILLION) 47
TABLE 8 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2019–2032 (USD MILLION) 47
TABLE 9 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 48
TABLE 10 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SENSORS, BY COUNTRY, 2019–2032 (USD MILLION) 48
TABLE 11 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TRANSMITTER AND RECEIVERS, BY COUNTRY, 2019–2032 (USD MILLION) 49
TABLE 12 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 51
TABLE 13 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR FINGERTIP SITE, BY COUNTRY, 2019–2032 (USD MILLION) 52
TABLE 14 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR ALTERNATE SITE, BY COUNTRY, 2019–2032 (USD MILLION) 52
TABLE 15 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 55
TABLE 16 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TYPE 2 DIABETES, BY COUNTRY, 2019–2032 (USD MILLION) 56
TABLE 17 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TYPE 1 DIABETES, BY COUNTRY, 2019–2032 (USD MILLION) 56
TABLE 18 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR GESTATIONAL DIABETES, BY COUNTRY, 2019–2032 (USD MILLION) 57
TABLE 19 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 59
TABLE 20 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2032 (USD MILLION) 60
TABLE 21 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR HOMECARE SETTINGS, BY COUNTRY, 2019–2032 (USD MILLION) 60
TABLE 22 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 63
TABLE 23 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 64
TABLE 24 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 64
TABLE 25 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 65
TABLE 26 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 65
TABLE 27 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 65
TABLE 28 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 65
TABLE 29 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 66
TABLE 30 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 66
TABLE 31 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 66
TABLE 32 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 66
TABLE 33 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 67
TABLE 34 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 67
TABLE 35 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 67
TABLE 36 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 67
TABLE 37 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 68
TABLE 38 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 68
TABLE 39 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 68
TABLE 40 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 68
TABLE 41 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 69
TABLE 42 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 69
TABLE 43 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 69
TABLE 44 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 69
TABLE 45 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 70
TABLE 46 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 70
TABLE 47 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 70
TABLE 48 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 70
TABLE 49 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 71
TABLE 50 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 71
TABLE 51 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71
TABLE 52 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 71
TABLE 53 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 72
TABLE 54 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 72
TABLE 55 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 72
TABLE 56 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 72
TABLE 57 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 73
TABLE 58 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 73
TABLE 59 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 73
TABLE 60 THAILAND: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION) 73
TABLE 61 THAILAND: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019–2032 (USD MILLION) 74
TABLE 62 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019–2032 (USD MILLION) 74
TABLE 63 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 74
TABLE 64 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019–2032 (USD MILLION) 74
TABLE 65 PUBLIC PLAYERS STOCK SUMMARY 78
TABLE 66 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 78
TABLE 67 COMPANY EXPANSION 79
TABLE 68 ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCTS OFFERED 81
TABLE 69 B. BRAUN SE: PRODUCTS OFFERED 84
TABLE 70 SINOCARE: PRODUCTS OFFERED 86
TABLE 71 I-SENS, INC.: PRODUCTS OFFERED 90
TABLE 72 TERUMO CORPORATION: PRODUCTS OFFERED 93
TABLE 73 DEXCOM, INC: PRODUCT OFFERED 96
TABLE 74 MEDTRONIC: PRODUCTS OFFERED 98
TABLE 75 ABBOTT: PRODUCTS OFFERED 101
TABLE 76 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 105
TABLE 77 YPSOMED HOLDING AG: PRODUCTS OFFERED 108
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET: STRUCTURE 18
FIGURE 2 APAC BLOOD GLUCOSE MONITORING MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 34
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 36
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 37
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET 39
FIGURE 6 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 43
FIGURE 7 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 44
FIGURE 8 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY PRODUCT, 2022 49
FIGURE 9 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, TESTING SITE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 50
FIGURE 10 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2022 & 2032 (USD MILLION) 51
FIGURE 11 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY TESTING SITE, 2022 53
FIGURE 12 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 54
FIGURE 13 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 55
FIGURE 14 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY GESTATIONAL DIABETES, 2022 57
FIGURE 15 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 58
FIGURE 16 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2022 & 2032 (USD MILLION) 59
FIGURE 17 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY END USER, 2022 61
FIGURE 18 ASIA-PACIFIC MARKET ANALYSIS: BLOOD GLUCOSE MONITORING MARKET, 2019-2032 (USD MILLION) 62
FIGURE 19 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION) 63
FIGURE 20 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE, BY COUNTRY, 2022 (%) 64
FIGURE 21 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 76
FIGURE 22 COMPETITOR DASHBOARD: ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET 77
FIGURE 23 ASCENSIA DIABETES CARE HOLDINGS AG: SWOT ANALYSIS 82
FIGURE 24 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 84
FIGURE 25 B. BRAUN SE: SWOT ANALYSIS 85
FIGURE 26 I-SENS, INC.: FINANCIAL OVERVIEW SNAPSHOT 89
FIGURE 27 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 92
FIGURE 28 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT 95
FIGURE 29 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 98
FIGURE 30 MEDTRONIC: SWOT ANALYSIS 99
FIGURE 31 ABBOTT: FINANCIAL OVERVIEW 101
FIGURE 32 ABBOTT: SWOT ANALYSIS 102
FIGURE 33 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 104
FIGURE 34 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 106
FIGURE 35 YPSOMED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT 108
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們